226 related articles for article (PubMed ID: 32062672)
1. Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation.
Ghannam JY; Xu X; Maric I; Dillon L; Li Y; Hsieh MM; Hourigan CS; Fitzhugh CD
Blood; 2020 Apr; 135(14):1185-1188. PubMed ID: 32062672
[TBL] [Abstract][Full Text] [Related]
2. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.
Yoshizato T; Nannya Y; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Suzuki H; Nagata Y; Sato Y; Kakiuchi N; Matsuo K; Onizuka M; Kataoka K; Chiba K; Tanaka H; Ueno H; Nakagawa MM; Przychodzen B; Haferlach C; Kern W; Aoki K; Itonaga H; Kanda Y; Sekeres MA; Maciejewski JP; Haferlach T; Miyazaki Y; Horibe K; Sanada M; Miyano S; Makishima H; Ogawa S
Blood; 2017 Apr; 129(17):2347-2358. PubMed ID: 28223278
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with
Ciurea SO; Chilkulwar A; Saliba RM; Chen J; Rondon G; Patel KP; Khogeer H; Shah AR; Randolph BV; Perez JMR; Popat U; Hosing CM; Bashir Q; Mehta R; Al-Atrash G; Im J; Khouri IF; Kebriaei P; Champlin RE
Blood; 2018 Jun; 131(26):2989-2992. PubMed ID: 29769261
[No Abstract] [Full Text] [Related]
5. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
Shih AH; Chung SS; Dolezal EK; Zhang SJ; Abdel-Wahab OI; Park CY; Nimer SD; Levine RL; Klimek VM
Haematologica; 2013 Jun; 98(6):908-12. PubMed ID: 23349305
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid Leukemia and Myelodysplastic Syndromes with
Sill H; Zebisch A; Haase D
Clin Cancer Res; 2020 Oct; 26(20):5304-5309. PubMed ID: 32816950
[TBL] [Abstract][Full Text] [Related]
8. Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither.
Jones RJ; DeBaun MR
Blood; 2021 Sep; 138(11):942-947. PubMed ID: 34115136
[TBL] [Abstract][Full Text] [Related]
9. Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease.
Fitzhugh CD
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):266-271. PubMed ID: 36485129
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation.
Rohatiner A
J Clin Oncol; 1994 Dec; 12(12):2521-3. PubMed ID: 7989924
[No Abstract] [Full Text] [Related]
11. What Are the Prospects for Treating TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia?
Wang C; Sallman DA
Cancer J; 2022 Jan-Feb 01; 28(1):51-61. PubMed ID: 35072374
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease and acute leukemia: one case report and an extensive review.
Cannas G; Poutrel S; Heiblig M; Labussière H; Larcher MV; Thomas X; Hot A
Ann Hematol; 2023 Jul; 102(7):1657-1667. PubMed ID: 37269388
[TBL] [Abstract][Full Text] [Related]
13. Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple
Lodé L; Ameur A; Coste T; Ménard A; Richebourg S; Gaillard JB; Le Bris Y; Béné MC; Lavabre-Bertrand T; Soussi T
Haematologica; 2018 Jan; 103(1):e13-e16. PubMed ID: 29079597
[No Abstract] [Full Text] [Related]
14. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
[TBL] [Abstract][Full Text] [Related]
15. Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
Hong S; Rybicki L; Gurnari C; Pagliuca S; Zhang A; Thomas D; Visconte V; Durrani J; Sobecks RM; Kalaycio M; Gerds AT; Carraway HE; Mukherjee S; Sekeres MA; Advani AS; Majhail NS; Hamilton BK; Patel BJ; Maciejewski JP
Bone Marrow Transplant; 2022 Oct; 57(10):1615-1619. PubMed ID: 35896698
[No Abstract] [Full Text] [Related]
16. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA
J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes.
Chang CK; Zhao YS; Xu F; Guo J; Zhang Z; He Q; Wu D; Wu LY; Su JY; Song LX; Xiao C; Li X
Br J Haematol; 2017 Feb; 176(4):600-608. PubMed ID: 27984642
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia.
McGraw KL; Nguyen J; Komrokji RS; Sallman D; Al Ali NH; Padron E; Lancet JE; Moscinski LC; List AF; Zhang L
Haematologica; 2016 Aug; 101(8):e320-3. PubMed ID: 27081179
[No Abstract] [Full Text] [Related]
19. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
Sill H
Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
